Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2000-02-17
2002-07-09
Celsa, Bennett (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S307000, C546S139000, C546S141000, C544S358000, C544S359000, C435S091500, C435S091500
Reexamination Certificate
active
06417195
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the synthesis of heterocyclic compounds based on the isoquinoline ring. More specifically, the invention provides novel isoquinoline derivatives as well as novel libraries comprised of such compounds.
2. Background Information
The process of discovering new therapeutically active compounds for a given indication involves the screening of all compounds from available compound collections. From the compounds tested one or more structure(s) is selected as a promising lead. A large number of related analogs are then synthesized in order to develop a structure-activity relationship and select one or more optimal compounds. With traditional one-at-a-time synthesis and biological testing of analogs, this optimization process is long and labor intensive. Adding significant numbers of new structures to the compound collections used in the initial screening step of the discovery and optimization process cannot be accomplished with traditional one-at-a-time synthesis methods, except over a time frame of months or even years. Faster methods are needed that allow for the preparation of up to thousands of related compounds in a matter of days or a few weeks. This need is particularly evident when it comes to synthesizing more complex compounds, such as isoquinolines.
Thus, improved methods for generating therapeutically useful heterocyclic compounds, such as isoquinoline derivatives, are desired. This invention satisfies these needs and provides related advantages as well. The present invention overcomes the known limitations to classical organic synthesis of isoquinolines as well as the shortcomings of combinatorial chemistry with heterocycles. The present invention combines the techniques of solid-phase synthesis of heterocycles and the general techniques of synthesis of combinatorial libraries to prepare new isoquinoline compounds.
SUMMARY OF THE INVENTION
The present invention relates to novel isoquinoline compounds, as well as libraries containing such compounds, of the following formula:
wherein R
1
to R
9
, X and Y have the meanings provided below.
REFERENCES:
patent: 5189043 (1993-02-01), Natsurari et al.
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5916899 (1999-06-01), Kiely et al.
patent: WO94/26775 (1994-11-01), None
patent: WO97/16428 (1997-05-01), None
patent: WO98/02741 (1998-01-01), None
patent: WO98/34111 (1998-08-01), None
patent: WO98/34115 (1998-08-01), None
patent: WO97/10221 (1999-03-01), None
patent: WO99/55679 (1999-11-01), None
Maia H.L.S.,Proceedings of the 23rd European Peptide SymposiumEscom Publishing 465-466 (1995).
Celsa Bennett
Law Offices of David Spolter
Lion Bioscience AG
Spolter David
LandOfFree
Isoquinoline derivatives and isoquinoline combinatorial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline derivatives and isoquinoline combinatorial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline derivatives and isoquinoline combinatorial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2911974